Nektar Therapeutics (NKTR)
37.27
+0.02
(+0.05%)
USD |
NASDAQ |
Nov 13, 16:00
37.17
-0.10
(-0.27%)
After-Hours: 19:59
Nektar Therapeutics Max Drawdown (5Y) : 99.39% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.39% |
| September 30, 2026 | 99.39% |
| August 31, 2026 | 99.39% |
| July 31, 2026 | 99.39% |
| June 30, 2026 | 99.39% |
| May 31, 2026 | 99.39% |
| April 30, 2026 | 99.39% |
| March 31, 2026 | 99.39% |
| February 28, 2026 | 99.39% |
| January 31, 2026 | 99.39% |
| December 31, 2025 | 99.39% |
| November 30, 2025 | 99.39% |
| October 31, 2025 | 99.39% |
| September 30, 2025 | 99.39% |
| August 31, 2025 | 99.39% |
| July 31, 2025 | 99.39% |
| June 30, 2025 | 99.39% |
| May 31, 2025 | 99.39% |
| April 30, 2025 | 99.39% |
| March 31, 2025 | 99.39% |
| February 28, 2025 | 99.39% |
| January 31, 2025 | 99.39% |
| December 31, 2024 | 99.39% |
| November 30, 2024 | 99.39% |
| October 31, 2024 | 99.39% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.39% |
| August 31, 2024 | 99.39% |
| July 31, 2024 | 99.39% |
| June 30, 2024 | 99.39% |
| May 31, 2024 | 99.39% |
| April 30, 2024 | 99.39% |
| March 31, 2024 | 99.39% |
| February 29, 2024 | 99.39% |
| January 31, 2024 | 99.39% |
| December 31, 2023 | 99.39% |
| November 30, 2023 | 99.39% |
| October 31, 2023 | 99.39% |
| September 30, 2023 | 99.39% |
| August 31, 2023 | 99.39% |
| July 31, 2023 | 99.39% |
| June 30, 2023 | 99.39% |
| May 31, 2023 | 99.39% |
| April 30, 2023 | 99.39% |
| March 31, 2023 | 99.39% |
| February 28, 2023 | 98.73% |
| January 31, 2023 | 98.13% |
| December 31, 2022 | 98.13% |
| November 30, 2022 | 97.42% |
| October 31, 2022 | 97.20% |
| September 30, 2022 | 97.20% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Inovio Pharmaceuticals, Inc. | 99.62% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Fortress Biotech, Inc. | 98.41% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.46 |
| Beta (5Y) | 1.443 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 124.0% |
| Historical Sharpe Ratio (5Y) | -0.271 |
| Historical Sortino (5Y) | -0.6717 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.47% |